Test Price
2,800 AED✅ Home Collection Available
CRYAB Gene Posterior Polar Cataract Type 2 Genetic Test in UAE | 2800 AED | DHA-Compliant
Executive Summary & Core Metrics
Executive Summary
This advanced genetic diagnostic test provides 99.9% sensitivity using ISO 9001:2015 accredited Next Generation Sequencing (NGS) technology. The service includes sterile home collection via temperature-controlled cold-chain logistics and VIP mobile phlebotomy (8 AM – 11 PM), followed by a mandatory telephonic post-test clinical guidance session with a DHA-licensed genetic counsellor. All procedures strictly comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-certified genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing test screens the entire coding region of the CRYAB gene for pathogenic variants associated with posterior polar cataract type 2, enabling early molecular diagnosis and precise family risk assessment.
| Feature | Our Test (NGS) | Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | Full exon & splice-site coverage with ≥99.9% analytic sensitivity | Limited to known mutation hotspots; may miss novel variants |
| Methodology | Next Generation Sequencing (Illumina NovaSeq) – DHA-compliant wet-lab | Sanger sequencing |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| Clinical Utility | Comprehensive risk stratification, carrier detection, and family cascade screening | Targeted confirmation only |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that this NGS-based test provides high-resolution detection of CRYAB variants. However, results must always be correlated with a complete ophthalmic examination and three-generation family pedigree. No irreversible clinical decisions should be made solely on a genetic report; collaboration with your ophthalmologist is critical for preserving vision and overall health.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Important
Do not discontinue any prescribed ophthalmic or systemic medication without consulting your doctor. Genetic results may inform long-term risk management but do not replace acute clinical care.
Safety Exclusion Criteria & Red Flags
- Individuals unable to provide informed consent (minors require guardian consent per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Patients currently experiencing acute eye trauma or active ocular infection.
- No prior pre-test genetic counselling session; counselling is mandatory before sample collection.
- Blood transfusion within the last 14 days may interfere with DNA testing; please inform the phlebotomist.
Seek immediate emergency care if you experience: sudden vision loss, severe eye pain, flashes/floaters with curtain-like visual field loss, or acute glaucoma symptoms (headache, nausea, red eye).
Patient FAQ & Clinical Guidance
1. What is the purpose of the CRYAB gene cataract test?
This test identifies disease-causing variants in the CRYAB gene to confirm posterior polar cataract type 2 diagnosis and guide familial risk counselling. It enables early molecular diagnosis and helps determine recurrence risks for family planning.
2. How is the sample collected and is home collection available?
Sample collection requires a single drop of blood on an FTA card or a standard venipuncture. Our DHA-certified VIP mobile phlebotomy service is available daily from 8 AM to 11 PM for home collection.
3. What is the turnaround time and how will I receive my results?
Results are ready in 3 to 4 weeks. We securely deliver the report by email and provide a mandatory telephonic post-test clinical guidance session with a genetic specialist to explain findings and recommend next steps.
4. Is genetic counselling included in the test price?
Yes, a pre-test counselling session is mandatory and included in the 2,800 AED fee. A post-test telephonic guidance session is also provided at no additional cost.
UAE Regulatory & Data Privacy Adherence
This service strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, de-identified, and stored on UAE sovereign servers. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
📞 WhatsApp Support: +971 54 548 8731 | ✉️ genetic.care@emirates.net
Clinical & Logistical Metadata
| Test Name | CRYAB Gene Posterior Polar Cataract Type 2 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral blood (2-5 ml EDTA) or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) – Illumina NovaSeq |
| ICD-10-CM Code | Q12.0, Z13.5, Z84.81 |
| LOINC Code | 101553-4 |
| DHA Facility License & Laboratory Address Invariants | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians